Bio-Works Technologies AB has signed a landmark licensing agreement with Amicogen Inc., a leading South Korean biotechnology company, to enable local manufacturing of agarose-based chromatography resins in South Korea. The agreement is a significant step in Bio-Works’ strategy to expand its manufacturing footprint and strengthen its position in the Asian biopharmaceutical market.